Floatz logo

Vls-1488

High Grade Serous Adenocarcinoma of Ovary

Volastra Therapeutics, Inc.Phase 1/2Active
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
89/ 100

Competitive context

114 Active assets in the High Grade Serous Adenocarcinoma of Ovary cohort.

Asset / SponsorPhaseRating
Carboplatin
National Cancer Institute (NCI)
Phase 3BBB
Olaparib
National Cancer Institute (NCI)
Phase 2/3BB
Letrozole
Memorial Sloan Kettering Cancer Center
Phase 3BB
Cyclophosphamide
Roswell Park Cancer Institute
Phase 2BB
Inno-206
National Cancer Institute (NCI)
Phase 3BB

View all 50 →

Same molecule, other indications

Vls-1488 is also rated in:

squamous cell lung carcinomaDormant
CCC
Indicative ·
48 / 100
View asset →
ovarian carcinosarcomaDormant
CCC
Indicative ·
48 / 100
View asset →
uterine carcinosarcomaDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →